CRVSbenzinga

Corvus Pharmaceuticals Releases Data From Phase 1 Placebo-Controlled Trial Of Soquelitinib In Atopic Dermatitis Cohort 2

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 13, 2025 by benzinga